| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | hippo signaling | 3.85e-06 | 55 | 40 | 4 | GO:0035329 | |
| GeneOntologyCellularComponent | TEAD-YAP complex | 1.07e-05 | 3 | 40 | 2 | GO:0140552 | |
| Domain | TEA | 1.80e-11 | 4 | 40 | 4 | PF01285 | |
| Domain | TEA_1 | 1.80e-11 | 4 | 40 | 4 | PS00554 | |
| Domain | TEA/ATTS_dom | 1.80e-11 | 4 | 40 | 4 | IPR000818 | |
| Domain | TEF_metazoa | 1.80e-11 | 4 | 40 | 4 | IPR016361 | |
| Domain | TEA | 1.80e-11 | 4 | 40 | 4 | SM00426 | |
| Domain | TEA_2 | 1.80e-11 | 4 | 40 | 4 | PS51088 | |
| Domain | Homeodomain-like | 6.80e-04 | 332 | 40 | 5 | IPR009057 | |
| Domain | ABC_membrane | 1.20e-03 | 24 | 40 | 2 | PF00664 | |
| Domain | ABC_TM1F | 1.63e-03 | 28 | 40 | 2 | PS50929 | |
| Domain | ABC1_TM_dom | 1.63e-03 | 28 | 40 | 2 | IPR011527 | |
| Domain | PDZ | 3.39e-03 | 141 | 40 | 3 | PF00595 | |
| Domain | ABC_transporter_CS | 3.65e-03 | 42 | 40 | 2 | IPR017871 | |
| Domain | PDZ | 3.89e-03 | 148 | 40 | 3 | SM00228 | |
| Domain | - | 4.04e-03 | 150 | 40 | 3 | 2.30.42.10 | |
| Domain | PDZ | 4.11e-03 | 151 | 40 | 3 | PS50106 | |
| Domain | PDZ | 4.19e-03 | 152 | 40 | 3 | IPR001478 | |
| Domain | ABC_TRANSPORTER_2 | 4.74e-03 | 48 | 40 | 2 | PS50893 | |
| Domain | ABC_tran | 4.74e-03 | 48 | 40 | 2 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 4.94e-03 | 49 | 40 | 2 | PS00211 | |
| Domain | ABC_transporter-like | 5.13e-03 | 50 | 40 | 2 | IPR003439 | |
| Domain | EGF_CA | 1.46e-02 | 86 | 40 | 2 | PF07645 | |
| Pathway | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | 1.08e-10 | 15 | 31 | 5 | M603 | |
| Pathway | REACTOME_RUNX3_REGULATES_YAP1_MEDIATED_TRANSCRIPTION | 2.86e-10 | 6 | 31 | 4 | MM15544 | |
| Pathway | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | 1.33e-09 | 8 | 31 | 4 | MM14816 | |
| Pathway | REACTOME_RUNX3_REGULATES_YAP1_MEDIATED_TRANSCRIPTION | 1.33e-09 | 8 | 31 | 4 | M27823 | |
| Pathway | WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS | 5.73e-08 | 18 | 31 | 4 | M39421 | |
| Pathway | WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS | 5.73e-08 | 18 | 31 | 4 | M39825 | |
| Pathway | WP_HIPPOYAP_SIGNALING | 1.36e-07 | 22 | 31 | 4 | M39821 | |
| Pathway | WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS | 9.55e-07 | 35 | 31 | 4 | M39430 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 3.19e-06 | 47 | 31 | 4 | M39829 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 2.20e-05 | 76 | 31 | 4 | MM15520 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 5.52e-05 | 96 | 31 | 4 | M27784 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 5.98e-05 | 98 | 31 | 4 | M39830 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 1.36e-04 | 121 | 31 | 4 | M39823 | |
| Pathway | REACTOME_FORMATION_OF_AXIAL_MESODERM | 4.19e-04 | 14 | 31 | 2 | M46441 | |
| Pubmed | 1.84e-12 | 4 | 42 | 4 | 8702974 | ||
| Pubmed | Comparative expression analysis of TEADs and their splice variants in mouse embryonic stem cells. | 1.84e-12 | 4 | 42 | 4 | 36516960 | |
| Pubmed | 1.84e-12 | 4 | 42 | 4 | 9889009 | ||
| Pubmed | The TEA domain: a novel, highly conserved DNA-binding motif. | 1.84e-12 | 4 | 42 | 4 | 2070413 | |
| Pubmed | 1.84e-12 | 4 | 42 | 4 | 9169843 | ||
| Pubmed | 2.56e-12 | 13 | 42 | 5 | 33984529 | ||
| Pubmed | 9.17e-12 | 5 | 42 | 4 | 9671946 | ||
| Pubmed | 9.17e-12 | 5 | 42 | 4 | 21527258 | ||
| Pubmed | 9.17e-12 | 5 | 42 | 4 | 19324877 | ||
| Pubmed | 9.17e-12 | 5 | 42 | 4 | 22677547 | ||
| Pubmed | TEAD mediates YAP-dependent gene induction and growth control. | 9.17e-12 | 5 | 42 | 4 | 18579750 | |
| Pubmed | 9.17e-12 | 5 | 42 | 4 | 10518497 | ||
| Pubmed | 2.30e-11 | 19 | 42 | 5 | 20596238 | ||
| Pubmed | 2.75e-11 | 6 | 42 | 4 | 11358867 | ||
| Pubmed | 2.75e-11 | 6 | 42 | 4 | 25995450 | ||
| Pubmed | 6.41e-11 | 7 | 42 | 4 | 14736747 | ||
| Pubmed | Tead proteins activate the Foxa2 enhancer in the node in cooperation with a second factor. | 6.41e-11 | 7 | 42 | 4 | 16207754 | |
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 8920920 | ||
| Pubmed | VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle. | 6.54e-09 | 4 | 42 | 3 | 31138678 | |
| Pubmed | YAP/TEAD-mediated transcription controls cellular senescence. | 6.54e-09 | 4 | 42 | 3 | 23576552 | |
| Pubmed | Tead transcription factors differentially regulate cortical development. | 6.54e-09 | 4 | 42 | 3 | 32170161 | |
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 9502435 | ||
| Pubmed | 8.77e-09 | 20 | 42 | 4 | 18978355 | ||
| Pubmed | Tead4 is required for specification of trophectoderm in pre-implantation mouse embryos. | 1.60e-08 | 23 | 42 | 4 | 18083014 | |
| Pubmed | The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. | 1.63e-08 | 5 | 42 | 3 | 20516196 | |
| Pubmed | 5.71e-08 | 7 | 42 | 3 | 12861002 | ||
| Pubmed | Mechanosignalling via integrins directs fate decisions of pancreatic progenitors. | 6.44e-08 | 32 | 42 | 4 | 30487608 | |
| Pubmed | AMPK modulates Hippo pathway activity to regulate energy homeostasis. | 1.95e-07 | 10 | 42 | 3 | 25751139 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 8921372 | ||
| Pubmed | Cellular prion protein participates in amyloid-β transcytosis across the blood-brain barrier. | 1.42e-06 | 2 | 42 | 2 | 22293988 | |
| Pubmed | TEAD1 and TEAD3 Play Redundant Roles in the Regulation of Human Epidermal Proliferation. | 1.42e-06 | 2 | 42 | 2 | 32142794 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 27725085 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 20048341 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 28178271 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 34810220 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 36266319 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 36347940 | ||
| Pubmed | Human Papillomavirus 16 E6 Upregulates APOBEC3B via the TEAD Transcription Factor. | 4.27e-06 | 3 | 42 | 2 | 28077648 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 25628125 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 17823374 | ||
| Pubmed | TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis. | 4.27e-06 | 3 | 42 | 2 | 28759040 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 26487755 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 10934189 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 25588835 | ||
| Pubmed | 7.19e-06 | 31 | 42 | 3 | 19796621 | ||
| Pubmed | Paraxis: a basic helix-loop-helix protein expressed in paraxial mesoderm and developing somites. | 8.53e-06 | 4 | 42 | 2 | 7729571 | |
| Pubmed | Loss of β2-spectrin prevents cardiomyocyte differentiation and heart development. | 8.53e-06 | 4 | 42 | 2 | 24064296 | |
| Pubmed | Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. | 8.53e-06 | 4 | 42 | 2 | 25751140 | |
| Pubmed | Transcription factor TEAD2 is involved in neural tube closure. | 8.53e-06 | 4 | 42 | 2 | 17868131 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 1.12e-05 | 908 | 42 | 8 | 19274049 | |
| Pubmed | 1.23e-05 | 117 | 42 | 4 | 22174793 | ||
| Pubmed | 1.42e-05 | 5 | 42 | 2 | 35302846 | ||
| Pubmed | Genomic structure and chromosomal mapping of the mouse transcription factor TEF-5 (Tead3) gene. | 1.42e-05 | 5 | 42 | 2 | 10341100 | |
| Pubmed | 1.42e-05 | 5 | 42 | 2 | 23386614 | ||
| Pubmed | 1.42e-05 | 5 | 42 | 2 | 28425913 | ||
| Pubmed | 1.57e-05 | 40 | 42 | 3 | 30865227 | ||
| Pubmed | Lhx9 gene expression during early limb development in mice requires the FGF signalling pathway. | 2.13e-05 | 6 | 42 | 2 | 26220830 | |
| Pubmed | 2.98e-05 | 7 | 42 | 2 | 27993983 | ||
| Pubmed | The cellular prion protein colocalizes with the dystroglycan complex in the brain. | 2.98e-05 | 7 | 42 | 2 | 11032878 | |
| Pubmed | 2.98e-05 | 7 | 42 | 2 | 31558711 | ||
| Pubmed | Limb deformity proteins: role in mesodermal induction of the apical ectodermal ridge. | 2.98e-05 | 7 | 42 | 2 | 9006074 | |
| Pubmed | 2.98e-05 | 7 | 42 | 2 | 8575323 | ||
| Pubmed | Meso1, a basic-helix-loop-helix protein involved in mammalian presomitic mesoderm development. | 3.97e-05 | 8 | 42 | 2 | 7597044 | |
| Pubmed | 3.97e-05 | 8 | 42 | 2 | 19660449 | ||
| Pubmed | Influence of mesodermal Fgf8 on the differentiation of neural crest-derived postganglionic neurons. | 3.97e-05 | 8 | 42 | 2 | 22040872 | |
| Pubmed | Molecular architecture of lineage allocation and tissue organization in early mouse embryo. | 3.97e-05 | 8 | 42 | 2 | 31391582 | |
| Pubmed | 3.97e-05 | 8 | 42 | 2 | 21385842 | ||
| Pubmed | 3.97e-05 | 8 | 42 | 2 | 17131403 | ||
| Pubmed | Development of the mammalian urethra is controlled by Fgfr2-IIIb. | 3.97e-05 | 8 | 42 | 2 | 15843416 | |
| Pubmed | Atlas of Musculoskeletal Stem Cells with the Soft and Hard Tissue Differentiation Architecture. | 3.97e-05 | 8 | 42 | 2 | 33304744 | |
| Pubmed | TET1 regulates fibroblast growth factor 8 transcription in gonadotropin releasing hormone neurons. | 5.10e-05 | 9 | 42 | 2 | 31361780 | |
| Pubmed | 5.10e-05 | 9 | 42 | 2 | 17913785 | ||
| Pubmed | Formin1 disruption confers oligodactylism and alters Bmp signaling. | 5.10e-05 | 9 | 42 | 2 | 19383632 | |
| Pubmed | 5.10e-05 | 9 | 42 | 2 | 7588050 | ||
| Pubmed | 6.37e-05 | 10 | 42 | 2 | 12808456 | ||
| Pubmed | 6.37e-05 | 10 | 42 | 2 | 16192310 | ||
| Pubmed | 6.37e-05 | 10 | 42 | 2 | 39107332 | ||
| Pubmed | Interplay between Pitx2 and Pax7 temporally governs specification of extraocular muscle stem cells. | 6.37e-05 | 10 | 42 | 2 | 38875306 | |
| Pubmed | Early embryogenesis in CHDFIDD mouse model reveals facial clefts and altered cranial neurogenesis. | 6.37e-05 | 10 | 42 | 2 | 38511331 | |
| Pubmed | Fgf receptor 3 activation promotes selective growth and expansion of occipitotemporal cortex. | 6.37e-05 | 10 | 42 | 2 | 19192266 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 7.25e-05 | 184 | 42 | 4 | 32908313 | |
| Pubmed | 7.78e-05 | 11 | 42 | 2 | 19429790 | ||
| Pubmed | 7.78e-05 | 11 | 42 | 2 | 19096130 | ||
| Pubmed | Disruption of G-protein γ5 subtype causes embryonic lethality in mice. | 7.78e-05 | 11 | 42 | 2 | 24599258 | |
| Pubmed | Ectodermal Organ Development Is Regulated by a microRNA-26b-Lef-1-Wnt Signaling Axis. | 7.78e-05 | 11 | 42 | 2 | 32760291 | |
| Pubmed | 7.78e-05 | 11 | 42 | 2 | 21989910 | ||
| Pubmed | 7.78e-05 | 11 | 42 | 2 | 37883229 | ||
| Pubmed | 9.32e-05 | 12 | 42 | 2 | 21452232 | ||
| Pubmed | Insm1 promotes neurogenic proliferation in delaminated otic progenitors. | 9.32e-05 | 12 | 42 | 2 | 26545349 | |
| Pubmed | Pancreatic neurogenin 3-expressing cells are unipotent islet precursors. | 9.32e-05 | 12 | 42 | 2 | 19793886 | |
| Pubmed | Dynamic temporal requirement of Wnt1 in midbrain dopamine neuron development. | 9.32e-05 | 12 | 42 | 2 | 23444360 | |
| Pubmed | 1.10e-04 | 13 | 42 | 2 | 20122914 | ||
| Pubmed | Sonic hedgehog is essential for first pharyngeal arch development. | 1.10e-04 | 13 | 42 | 2 | 16492970 | |
| Pubmed | 1.10e-04 | 13 | 42 | 2 | 34912016 | ||
| Pubmed | Differentiation of pluripotent stem cells to muscle fiber to model Duchenne muscular dystrophy. | 1.10e-04 | 13 | 42 | 2 | 26237517 | |
| Pubmed | Abnormal development of the apical ectodermal ridge and polysyndactyly in Megf7-deficient mice. | 1.10e-04 | 13 | 42 | 2 | 16207730 | |
| Pubmed | 1.28e-04 | 14 | 42 | 2 | 26674308 | ||
| Pubmed | 1.28e-04 | 14 | 42 | 2 | 9834182 | ||
| Pubmed | 1.28e-04 | 14 | 42 | 2 | 25581370 | ||
| Pubmed | VGLL4 plays a critical role in heart valve development and homeostasis. | 1.28e-04 | 14 | 42 | 2 | 30789911 | |
| Interaction | VGLL3 interactions | 5.00e-09 | 72 | 39 | 6 | int:VGLL3 | |
| Interaction | VGLL1 interactions | 2.80e-08 | 17 | 39 | 4 | int:VGLL1 | |
| Interaction | TIAM1 interactions | 1.19e-07 | 205 | 39 | 7 | int:TIAM1 | |
| Interaction | VGLL4 interactions | 1.74e-07 | 26 | 39 | 4 | int:VGLL4 | |
| Interaction | MYH7 interactions | 1.44e-06 | 101 | 39 | 5 | int:MYH7 | |
| Interaction | LIMA1 interactions | 1.61e-05 | 429 | 39 | 7 | int:LIMA1 | |
| Interaction | GIGYF1 interactions | 2.23e-05 | 177 | 39 | 5 | int:GIGYF1 | |
| Interaction | ST6GALNAC1 interactions | 3.64e-05 | 5 | 39 | 2 | int:ST6GALNAC1 | |
| Interaction | VGLL2 interactions | 3.64e-05 | 5 | 39 | 2 | int:VGLL2 | |
| Interaction | EXOC3L4 interactions | 5.45e-05 | 6 | 39 | 2 | int:EXOC3L4 | |
| Interaction | CLBA1 interactions | 5.45e-05 | 6 | 39 | 2 | int:CLBA1 | |
| Interaction | MAP3K21 interactions | 6.40e-05 | 112 | 39 | 4 | int:MAP3K21 | |
| Interaction | MELK interactions | 6.40e-05 | 112 | 39 | 4 | int:MELK | |
| Interaction | DCLK1 interactions | 1.04e-04 | 127 | 39 | 4 | int:DCLK1 | |
| Interaction | KSR1 interactions | 1.21e-04 | 132 | 39 | 4 | int:KSR1 | |
| Interaction | BCAS1 interactions | 1.63e-04 | 10 | 39 | 2 | int:BCAS1 | |
| Interaction | MMP17 interactions | 1.63e-04 | 10 | 39 | 2 | int:MMP17 | |
| Interaction | PHLDB2 interactions | 1.65e-04 | 143 | 39 | 4 | int:PHLDB2 | |
| Interaction | MAGI1 interactions | 1.83e-04 | 147 | 39 | 4 | int:MAGI1 | |
| Interaction | CGN interactions | 2.08e-04 | 152 | 39 | 4 | int:CGN | |
| Interaction | CDC25C interactions | 2.30e-04 | 156 | 39 | 4 | int:CDC25C | |
| Interaction | NAT8L interactions | 2.38e-04 | 12 | 39 | 2 | int:NAT8L | |
| Interaction | RASAL2 interactions | 2.42e-04 | 158 | 39 | 4 | int:RASAL2 | |
| Interaction | KRT73 interactions | 2.57e-04 | 64 | 39 | 3 | int:KRT73 | |
| Interaction | ZBTB21 interactions | 2.60e-04 | 161 | 39 | 4 | int:ZBTB21 | |
| Interaction | CRABP1 interactions | 2.81e-04 | 13 | 39 | 2 | int:CRABP1 | |
| Interaction | STARD13 interactions | 3.08e-04 | 68 | 39 | 3 | int:STARD13 | |
| Interaction | CAMSAP2 interactions | 3.12e-04 | 169 | 39 | 4 | int:CAMSAP2 | |
| GeneFamily | TEA domain transcription factors | 1.04e-11 | 4 | 34 | 4 | 1183 | |
| GeneFamily | PDZ domain containing | 2.88e-03 | 152 | 34 | 3 | 1220 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 1.11e-05 | 777 | 40 | 9 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | 1.67e-05 | 818 | 40 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.72e-05 | 337 | 40 | 6 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | 1.01e-04 | 797 | 40 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | 1.21e-04 | 818 | 40 | 8 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000 | 1.41e-04 | 837 | 40 | 8 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_100 | 1.54e-04 | 10 | 40 | 2 | gudmap_kidney_P1_CapMes_Crym_k2_100 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|Epithelial / Condition, Lineage and Cell class | 3.00e-08 | 197 | 42 | 6 | 78ed2810e5a765327e7a6da0ca5d4854bf7a0b6f | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.10e-08 | 198 | 42 | 6 | 7225a6194c52b01c581e58d3cda107c4af96dc4f | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 4.21e-07 | 161 | 42 | 5 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-07 | 172 | 42 | 5 | e495efd25aec60b97ac2b5aa861651bd73174a17 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.19e-07 | 174 | 42 | 5 | 1779e67382cb2644534ffb5b9b8f28d32935f4ea | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.19e-07 | 174 | 42 | 5 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | droplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.55e-07 | 176 | 42 | 5 | b17317ac41d3215db55a38cbd3366c0947f7a2a3 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.94e-07 | 183 | 42 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 7.94e-07 | 183 | 42 | 5 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-07 | 184 | 42 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-07 | 184 | 42 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-07 | 184 | 42 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Mild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 8.37e-07 | 185 | 42 | 5 | c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 9.06e-07 | 188 | 42 | 5 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 9.30e-07 | 189 | 42 | 5 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-06 | 194 | 42 | 5 | 7a66bd7d4fc9c6db861cedd2487f241e406869d1 | |
| ToppCell | PCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung | 1.06e-06 | 194 | 42 | 5 | 5759c83308df017f1faae248e9b85388e25254f0 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class | 1.11e-06 | 196 | 42 | 5 | dd32046067d93b9484cfbf1d7826a436a3d9f0e9 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.23e-06 | 200 | 42 | 5 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.27e-05 | 152 | 42 | 4 | f748ee34167f79ecda116aa1914afab47403385a | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.51e-05 | 159 | 42 | 4 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 160 | 42 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 160 | 42 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 165 | 42 | 4 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-05 | 168 | 42 | 4 | 52fd65024af8683db11d931f7563cbe8eb815d1c | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.88e-05 | 168 | 42 | 4 | 6a233045638cb83dab64789b996b7598c325001e | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.92e-05 | 169 | 42 | 4 | 4db49b7eaea34e6558ee73b01e76315e99cc880b | |
| ToppCell | Club_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.92e-05 | 169 | 42 | 4 | 03b303af8a26c6ff196507fe24f5bd3d75d7b1af | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-05 | 170 | 42 | 4 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 173 | 42 | 4 | a5172dee859bf6c2eed46c48bd64dfef0ff9f28f | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 173 | 42 | 4 | 639b5b0b33ce5aa0bc26363c059717012ddc14c0 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.16e-05 | 174 | 42 | 4 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-05 | 174 | 42 | 4 | 42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-05 | 177 | 42 | 4 | 4197cf2b1e743230c821f422836fa5991b155a52 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 177 | 42 | 4 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.36e-05 | 178 | 42 | 4 | 7975bf0a3146ee0efa4f547af5977e6bf0ba71fd | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.41e-05 | 179 | 42 | 4 | 6718cadcc2d3b64717ed84244ef1242d392662dc | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.41e-05 | 179 | 42 | 4 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.52e-05 | 181 | 42 | 4 | 0c5bc1660b8fc1e905ab4230202862de5be46ebd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 181 | 42 | 4 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.52e-05 | 181 | 42 | 4 | f83565f09dd971c5cad2704a4a86bca0accd955e | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.52e-05 | 181 | 42 | 4 | be4f35c9eb5b3083acb2264128f095fac1f3da45 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 181 | 42 | 4 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.52e-05 | 181 | 42 | 4 | f2ebeb4941510c4b6e50f2379c574d1778d6ced1 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating-Lymphatic_EC_proliferating_L.2.5.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.57e-05 | 182 | 42 | 4 | f703963b5d1e8c1f95d78807521048553b0792d8 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 182 | 42 | 4 | c84f44391932080df31c8765e363c3dff64b2bd1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-05 | 182 | 42 | 4 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-05 | 182 | 42 | 4 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.57e-05 | 182 | 42 | 4 | ebd177ad5eac51bf2db0657596618bdf1e5d46e1 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 2.63e-05 | 183 | 42 | 4 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.63e-05 | 183 | 42 | 4 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.68e-05 | 184 | 42 | 4 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.68e-05 | 184 | 42 | 4 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.68e-05 | 184 | 42 | 4 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.74e-05 | 185 | 42 | 4 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 2.74e-05 | 185 | 42 | 4 | 4abe04198ab5047c211f8d09cdb9650fa52a3cd6 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 2.74e-05 | 185 | 42 | 4 | 9d3168c7f0b1d739f78b368969cf5c77ce202b97 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-05 | 185 | 42 | 4 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-05 | 185 | 42 | 4 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-05 | 186 | 42 | 4 | ec6d0c29e196e374baa96dd3d506f489c959e77e | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-05 | 186 | 42 | 4 | 3993f1ef8a33b8a75dfd3db8d4845b5afbb0bb3d | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|COPD / Disease state, Lineage and Cell class | 2.80e-05 | 186 | 42 | 4 | 23c7d0e8372a71546d687278b985f761d282f92f | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.86e-05 | 187 | 42 | 4 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.92e-05 | 188 | 42 | 4 | 33afe31b1093d317dc38c324197c6e91bf6c39d3 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 2.98e-05 | 189 | 42 | 4 | c76d8af2e0aa4a83ee0c3439c894566fbf117dd3 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 2.98e-05 | 189 | 42 | 4 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.98e-05 | 189 | 42 | 4 | d049f33115610bda4489968759f754730698b9cd | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.98e-05 | 189 | 42 | 4 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-05 | 189 | 42 | 4 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-05 | 190 | 42 | 4 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-05 | 190 | 42 | 4 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.04e-05 | 190 | 42 | 4 | 3c337374d89e69cc0a78e65a4a7e21db7b050fcd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.04e-05 | 190 | 42 | 4 | 23f2ac4da431211084bb6ab0494c2e0b69547cb6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 191 | 42 | 4 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 191 | 42 | 4 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 191 | 42 | 4 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.10e-05 | 191 | 42 | 4 | 588015d76b68488da6aa6603777682f3d81592bf | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 191 | 42 | 4 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 191 | 42 | 4 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 191 | 42 | 4 | 1caf726bd07fdca389e678fc16304a6ef1790423 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 191 | 42 | 4 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 191 | 42 | 4 | 3d60c46bced2984c27a1fcf2910bc38b31fb0148 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 191 | 42 | 4 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-05 | 192 | 42 | 4 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-05 | 192 | 42 | 4 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-05 | 193 | 42 | 4 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 3.23e-05 | 193 | 42 | 4 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 3.23e-05 | 193 | 42 | 4 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.23e-05 | 193 | 42 | 4 | ecbe1bd16df547427da5e69a3017300e766c2899 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 194 | 42 | 4 | 2cac1b9c4da01faaec9a67ec06f47a7060760225 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.30e-05 | 194 | 42 | 4 | e0228f593c3493175962a4817500d4337ddc4e88 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.30e-05 | 194 | 42 | 4 | 8b81f039f5b25d35a4d5a41b27d4d9360ba22f15 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.30e-05 | 194 | 42 | 4 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.30e-05 | 194 | 42 | 4 | 2172d951896265243d14996eacce5aab5e14e26e | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.30e-05 | 194 | 42 | 4 | d840c1949c328779426c9172e02da09e968f0567 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.30e-05 | 194 | 42 | 4 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.37e-05 | 195 | 42 | 4 | 3f8ed20ad17afe1545e574e5ca5fe33c3704c7f3 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.37e-05 | 195 | 42 | 4 | b57132802cb977551e214880984f3edcd375474f | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.43e-05 | 196 | 42 | 4 | 4924a36a81d62863c1004b8c76f8096a1f89c548 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.43e-05 | 196 | 42 | 4 | 2c3fbfbb08cd327cd97b3fa5a6f83b6d50771fb7 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.41e-04 | 49 | 27 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CELL_CYCLE | |
| Computational | Neighborhood of CENPF | 4.84e-04 | 62 | 27 | 3 | GNF2_CENPF | |
| Computational | Neighborhood of CDC2 | 4.84e-04 | 62 | 27 | 3 | GNF2_CDC2 | |
| Drug | methyl vinyl ketone | 7.05e-06 | 21 | 41 | 3 | CID000006570 | |
| Drug | AC1NSGRQ | 9.48e-06 | 3 | 41 | 2 | CID005333904 | |
| Drug | 2,4,4'-trichlorobiphenyl | MKI67 CNTN4 KCNQ2 TEAD2 RIMS1 CKAP2 DMD TSHZ2 CCNB2 ASXL3 FAT3 | 2.79e-05 | 1411 | 41 | 11 | ctd:C081766 |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | MKI67 CNTN4 KCNQ2 TEAD2 RIMS1 CKAP2 DMD TSHZ2 CCNB2 ASXL3 FAT3 | 3.39e-05 | 1441 | 41 | 11 | ctd:C009828 |
| Drug | Mcat | 3.41e-05 | 35 | 41 | 3 | CID003080785 | |
| Drug | vinyl carbamate | 4.38e-05 | 38 | 41 | 3 | CID000027492 | |
| Drug | Solutol HS 15 | 4.72e-05 | 6 | 41 | 2 | CID000124898 | |
| Drug | aminoanthraquinone | 4.72e-05 | 6 | 41 | 2 | CID000008341 | |
| Disease | Growth Disorders | 1.60e-05 | 36 | 40 | 3 | C0018273 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 6.41e-05 | 9 | 40 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | Facies | 8.01e-05 | 10 | 40 | 2 | C0282631 | |
| Disease | prostatic hypertrophy (is_marker_for) | 9.78e-05 | 11 | 40 | 2 | DOID:11132 (is_marker_for) | |
| Disease | uric acid measurement | 1.61e-04 | 610 | 40 | 6 | EFO_0004761 | |
| Disease | Neurodevelopmental Disorders | 2.75e-04 | 93 | 40 | 3 | C1535926 | |
| Disease | Colorectal Carcinoma | 3.42e-04 | 702 | 40 | 6 | C0009402 | |
| Disease | diabetes mellitus (implicated_via_orthology) | 5.70e-04 | 26 | 40 | 2 | DOID:9351 (implicated_via_orthology) | |
| Disease | Child Development Disorders, Specific | 7.11e-04 | 29 | 40 | 2 | C0085997 | |
| Disease | Child Development Deviations | 7.11e-04 | 29 | 40 | 2 | C0085996 | |
| Disease | Developmental Disabilities | 7.61e-04 | 30 | 40 | 2 | C0008073 | |
| Disease | Mental Retardation, Psychosocial | 8.90e-04 | 139 | 40 | 3 | C0025363 | |
| Disease | Profound Mental Retardation | 8.90e-04 | 139 | 40 | 3 | C0020796 | |
| Disease | Mental deficiency | 8.90e-04 | 139 | 40 | 3 | C0917816 | |
| Disease | urate measurement | 1.22e-03 | 895 | 40 | 6 | EFO_0004531 | |
| Disease | Craniofacial Abnormalities | 1.24e-03 | 156 | 40 | 3 | C0376634 | |
| Disease | lung cancer (is_marker_for) | 1.29e-03 | 39 | 40 | 2 | DOID:1324 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SGTRVRIKKTNSTFN | 991 | Q68DN1 | |
| QNIHRKTTASTRKVS | 781 | P13569 | |
| RTITTRSNSIKQGKD | 831 | Q9Y6K1 | |
| TQHRNTSKKAQIIGS | 906 | Q2M3G0 | |
| KLRSKVTNSVQVITH | 431 | Q2M329 | |
| RKIRTVGNQTSTKIT | 851 | Q8IWV2 | |
| QQSSGRIDIIHSKKT | 2046 | P11532 | |
| RNKTHKQGSTQSRLE | 921 | Q9C0F0 | |
| AQSDSTTQRRTVGKK | 551 | Q9UHB7 | |
| HSNTRDTVKQGISRT | 261 | Q8WWK9 | |
| LSSQVQRVVKTHSKG | 336 | Q68DA7 | |
| QTRVKLTKRSGHTQT | 341 | P43378 | |
| SRKSKQHQSSVRNVS | 801 | Q9H2X6 | |
| TTTRHKRTANPSKTI | 271 | Q14677 | |
| STVTTRIVSQIKTKG | 391 | Q9NRR6 | |
| TKSINRAHKTTGTNK | 3251 | Q07954 | |
| TKSHSRLSSQIQVVG | 1331 | Q86VH2 | |
| IVKIVRSSSSTGQKN | 686 | O43526 | |
| VTTTASGKRIRKNHA | 266 | P56270 | |
| GKLTQTSGKTTQTHR | 2016 | P46013 | |
| TTASTKRHLRTRVQK | 2716 | P46013 | |
| TGSSRRKHVVQAQKL | 866 | O75161 | |
| RHSRKSERSSIQKQT | 1161 | Q86UR5 | |
| SERSSIQKQTRKGTA | 1166 | Q86UR5 | |
| SRTSGKHVQVLANKR | 76 | P55075 | |
| NSKVKSHVTIRRTVL | 21 | O95067 | |
| SKSGVITLSNHRKQR | 2446 | Q8TDW7 | |
| KRRTTVTESLQHKGN | 6 | Q3T8J9 | |
| VGRKSLQVQQHSKRT | 86 | Q8IY85 | |
| HKKVGRRVSQTSNEF | 271 | Q5H9B9 | |
| KLTLGRSQKHTRAQT | 136 | P0C7X4 | |
| HNVIKRRNTTTGASA | 351 | O43166 | |
| TRKLTASRTVSEKHQ | 171 | Q9NSC7 | |
| GTHDQSSKERKTRQV | 466 | Q9ULL8 | |
| TGKTRTRKQVSSHIQ | 91 | Q15562 | |
| QKQTSSGTKSRSHGR | 201 | Q8WXF0 | |
| KTRRRSSTTHVKQAI | 176 | Q96A58 | |
| QTTGRKQSVSRSLKH | 411 | Q8N957 | |
| TGKTRTRKQVSSHIQ | 81 | Q99594 | |
| STKQITFIRIHKGSQ | 491 | Q96GC6 | |
| NITIKQHTVTTTTKG | 181 | P04156 | |
| KTRTRKQVSSHIQVL | 91 | Q15561 | |
| VSSEVSTLHKRKGRQ | 831 | Q9NRE2 | |
| TGKTRTRKQVSSHIQ | 81 | P28347 | |
| VHRSKKTNTVRNSGE | 216 | Q8IZ26 | |
| SRSLSISRNKTKQVH | 881 | Q9C0D4 |